Specialty Vaccine Company PaxVax, Inc. Appoints Nima Farzan As President

PaxVax, Inc., a specialty vaccine company focused on travel and biodefense, today announced the appointment of Nima Farzan as President and Chief Operating Officer (COO). Mr. Farzan, who has served as PaxVax COO for the past three years, will be responsible for the company's global operations including the finance, production and commercial functions. The company also announced today that Mr. Farzan has joined the PaxVax Board of Directors. Kenneth Kelley will continue to serve as the company's Chief Executive Officer and as a Director.

Suggested Articles

A TGen-led research team found that increased activity of the gene AEBP1 drives severe liver fibrosis in nonalcoholic steatohepatitis.

Days after announcing its R&D chief was stepping down, Gilead announced it will be buying a few of Novartis’ unwanted early-stage infection assets.

Mallinckrodt is teaming up with Silence Therapeutics to develop an RNAi program aimed at a group of proteins that play a part in promoting inflammation.